Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model

Akihiko Shimizu, Muneshige Kaibara, Osmar A. Centurion, Kakota Gaston Kapuku, Tetsuya Hirata, Masahiko Fukatani, Katsusuke Yano, Kunitake Hashiba

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Numerous studies have shown that E-4031 generally prolongs the atrial effective refractory period (AERP) without affecting cardiac conduction. The effects of E-4031 on AERP and cardiac conduction at short cycle lengths (CLs) close to the AERP were measured in 12 dogs with sterile pericarditis. Three pairs of electrodes were sutured at three sites in the atria 4 days after the model was created. We measured AERP and maximum conduction delay (MCD) after 8 beats train at CLs of 400, 300, 200 and 150 ms before and during continuous infusion of E-4031 (0.1 μg/kg/min) that followed an initial dose of 10 μg/kg/min/5 min. E-4031 interrupted sustained atrial flutter (AF) (≥10 min) in 4 of 5 episodes and atrial fibrillation (≥10 min) in 4 of 4. The CL of AF defined as a rapid atrial rhythm (rate ≥240 beats/min) in five episodes studied in the sterile pericarditis model was significantly (p < 0.005) prolonged from 120 ± 8 to 160 ± 17 ms. There were significant (p < 0.005) increases in AERP at each CL, and prolongation of AERP was 39 ± 18, 31 ± 14, 23 ± 14, and 16 ± 14 ms at CL 400, 300, 200, and 150 ms, respectively. E-4031 produced less prolongation of AERP at short pacing CLs and had no effect on conduction time during atrial rapid pacing at CLs > 150 ms. E-4031 did not prolong MCD at CL 400 ms, but did prolong MCD at CLs of 300, 200, and 150 ms, despite prolongation of AERP. Thus, at short pacing CLs close to that of AF1, the increase in prolongation of AERP was less, whereas the increase in atrial conduction delay was greater. These results demonstrate that (a) E-4031 prolongs AF1 CLs and effectively converts AF and atrial fibrillation to normal sinus rhythm in the pericarditis model; (b) at short CLs close to the CL of AF, prolongation of the AERP after E-4031 treatment was less than that observed at longer CLs; and (c) at short CLs close to the CL of AF, the increase in atrial conduction delay after E-4031 was greater than that observed at longer CLs.

Original languageEnglish (US)
Pages (from-to)656-662
Number of pages7
JournalJournal of Cardiovascular Pharmacology
Volume21
Issue number4
DOIs
StatePublished - Jan 1 1993

Fingerprint

Atrial Flutter
Pericarditis
Canidae
Atrial Fibrillation
E 4031
Electrodes
Dogs

Keywords

  • Atrial fibrillation
  • Atrial flutter
  • E-4031
  • Sterile pericarditis model

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model. / Shimizu, Akihiko; Kaibara, Muneshige; Centurion, Osmar A.; Kapuku, Kakota Gaston; Hirata, Tetsuya; Fukatani, Masahiko; Yano, Katsusuke; Hashiba, Kunitake.

In: Journal of Cardiovascular Pharmacology, Vol. 21, No. 4, 01.01.1993, p. 656-662.

Research output: Contribution to journalArticle

Shimizu, Akihiko ; Kaibara, Muneshige ; Centurion, Osmar A. ; Kapuku, Kakota Gaston ; Hirata, Tetsuya ; Fukatani, Masahiko ; Yano, Katsusuke ; Hashiba, Kunitake. / Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model. In: Journal of Cardiovascular Pharmacology. 1993 ; Vol. 21, No. 4. pp. 656-662.
@article{56385d183b3b47b1909041dd2ffd8625,
title = "Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model",
abstract = "Numerous studies have shown that E-4031 generally prolongs the atrial effective refractory period (AERP) without affecting cardiac conduction. The effects of E-4031 on AERP and cardiac conduction at short cycle lengths (CLs) close to the AERP were measured in 12 dogs with sterile pericarditis. Three pairs of electrodes were sutured at three sites in the atria 4 days after the model was created. We measured AERP and maximum conduction delay (MCD) after 8 beats train at CLs of 400, 300, 200 and 150 ms before and during continuous infusion of E-4031 (0.1 μg/kg/min) that followed an initial dose of 10 μg/kg/min/5 min. E-4031 interrupted sustained atrial flutter (AF) (≥10 min) in 4 of 5 episodes and atrial fibrillation (≥10 min) in 4 of 4. The CL of AF defined as a rapid atrial rhythm (rate ≥240 beats/min) in five episodes studied in the sterile pericarditis model was significantly (p < 0.005) prolonged from 120 ± 8 to 160 ± 17 ms. There were significant (p < 0.005) increases in AERP at each CL, and prolongation of AERP was 39 ± 18, 31 ± 14, 23 ± 14, and 16 ± 14 ms at CL 400, 300, 200, and 150 ms, respectively. E-4031 produced less prolongation of AERP at short pacing CLs and had no effect on conduction time during atrial rapid pacing at CLs > 150 ms. E-4031 did not prolong MCD at CL 400 ms, but did prolong MCD at CLs of 300, 200, and 150 ms, despite prolongation of AERP. Thus, at short pacing CLs close to that of AF1, the increase in prolongation of AERP was less, whereas the increase in atrial conduction delay was greater. These results demonstrate that (a) E-4031 prolongs AF1 CLs and effectively converts AF and atrial fibrillation to normal sinus rhythm in the pericarditis model; (b) at short CLs close to the CL of AF, prolongation of the AERP after E-4031 treatment was less than that observed at longer CLs; and (c) at short CLs close to the CL of AF, the increase in atrial conduction delay after E-4031 was greater than that observed at longer CLs.",
keywords = "Atrial fibrillation, Atrial flutter, E-4031, Sterile pericarditis model",
author = "Akihiko Shimizu and Muneshige Kaibara and Centurion, {Osmar A.} and Kapuku, {Kakota Gaston} and Tetsuya Hirata and Masahiko Fukatani and Katsusuke Yano and Kunitake Hashiba",
year = "1993",
month = "1",
day = "1",
doi = "10.1097/00005344-199304000-00021",
language = "English (US)",
volume = "21",
pages = "656--662",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model

AU - Shimizu, Akihiko

AU - Kaibara, Muneshige

AU - Centurion, Osmar A.

AU - Kapuku, Kakota Gaston

AU - Hirata, Tetsuya

AU - Fukatani, Masahiko

AU - Yano, Katsusuke

AU - Hashiba, Kunitake

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Numerous studies have shown that E-4031 generally prolongs the atrial effective refractory period (AERP) without affecting cardiac conduction. The effects of E-4031 on AERP and cardiac conduction at short cycle lengths (CLs) close to the AERP were measured in 12 dogs with sterile pericarditis. Three pairs of electrodes were sutured at three sites in the atria 4 days after the model was created. We measured AERP and maximum conduction delay (MCD) after 8 beats train at CLs of 400, 300, 200 and 150 ms before and during continuous infusion of E-4031 (0.1 μg/kg/min) that followed an initial dose of 10 μg/kg/min/5 min. E-4031 interrupted sustained atrial flutter (AF) (≥10 min) in 4 of 5 episodes and atrial fibrillation (≥10 min) in 4 of 4. The CL of AF defined as a rapid atrial rhythm (rate ≥240 beats/min) in five episodes studied in the sterile pericarditis model was significantly (p < 0.005) prolonged from 120 ± 8 to 160 ± 17 ms. There were significant (p < 0.005) increases in AERP at each CL, and prolongation of AERP was 39 ± 18, 31 ± 14, 23 ± 14, and 16 ± 14 ms at CL 400, 300, 200, and 150 ms, respectively. E-4031 produced less prolongation of AERP at short pacing CLs and had no effect on conduction time during atrial rapid pacing at CLs > 150 ms. E-4031 did not prolong MCD at CL 400 ms, but did prolong MCD at CLs of 300, 200, and 150 ms, despite prolongation of AERP. Thus, at short pacing CLs close to that of AF1, the increase in prolongation of AERP was less, whereas the increase in atrial conduction delay was greater. These results demonstrate that (a) E-4031 prolongs AF1 CLs and effectively converts AF and atrial fibrillation to normal sinus rhythm in the pericarditis model; (b) at short CLs close to the CL of AF, prolongation of the AERP after E-4031 treatment was less than that observed at longer CLs; and (c) at short CLs close to the CL of AF, the increase in atrial conduction delay after E-4031 was greater than that observed at longer CLs.

AB - Numerous studies have shown that E-4031 generally prolongs the atrial effective refractory period (AERP) without affecting cardiac conduction. The effects of E-4031 on AERP and cardiac conduction at short cycle lengths (CLs) close to the AERP were measured in 12 dogs with sterile pericarditis. Three pairs of electrodes were sutured at three sites in the atria 4 days after the model was created. We measured AERP and maximum conduction delay (MCD) after 8 beats train at CLs of 400, 300, 200 and 150 ms before and during continuous infusion of E-4031 (0.1 μg/kg/min) that followed an initial dose of 10 μg/kg/min/5 min. E-4031 interrupted sustained atrial flutter (AF) (≥10 min) in 4 of 5 episodes and atrial fibrillation (≥10 min) in 4 of 4. The CL of AF defined as a rapid atrial rhythm (rate ≥240 beats/min) in five episodes studied in the sterile pericarditis model was significantly (p < 0.005) prolonged from 120 ± 8 to 160 ± 17 ms. There were significant (p < 0.005) increases in AERP at each CL, and prolongation of AERP was 39 ± 18, 31 ± 14, 23 ± 14, and 16 ± 14 ms at CL 400, 300, 200, and 150 ms, respectively. E-4031 produced less prolongation of AERP at short pacing CLs and had no effect on conduction time during atrial rapid pacing at CLs > 150 ms. E-4031 did not prolong MCD at CL 400 ms, but did prolong MCD at CLs of 300, 200, and 150 ms, despite prolongation of AERP. Thus, at short pacing CLs close to that of AF1, the increase in prolongation of AERP was less, whereas the increase in atrial conduction delay was greater. These results demonstrate that (a) E-4031 prolongs AF1 CLs and effectively converts AF and atrial fibrillation to normal sinus rhythm in the pericarditis model; (b) at short CLs close to the CL of AF, prolongation of the AERP after E-4031 treatment was less than that observed at longer CLs; and (c) at short CLs close to the CL of AF, the increase in atrial conduction delay after E-4031 was greater than that observed at longer CLs.

KW - Atrial fibrillation

KW - Atrial flutter

KW - E-4031

KW - Sterile pericarditis model

UR - http://www.scopus.com/inward/record.url?scp=0027465050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027465050&partnerID=8YFLogxK

U2 - 10.1097/00005344-199304000-00021

DO - 10.1097/00005344-199304000-00021

M3 - Article

VL - 21

SP - 656

EP - 662

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 4

ER -